Ureterocystoplasty in Boys with Valve Bladder Syndrome-Is This Method Still up to Date?

Area of Science:

• Pediatric Urology
• Surgical Innovation
• Renal Function Preservation

Background:

• Posterior urethral valves (PUV) pose risks to renal function and long-term urinary tract health.
• Some boys with PUV require additional surgery to enhance bladder capacity and function.
• Ureterocytoplasty (UCP) is a surgical technique utilizing ureteral tissue for bladder augmentation.

Purpose of the Study:

• To evaluate the long-term efficacy and safety of ureterocytoplasty (UCP) in pediatric patients with posterior urethral valves (PUV).
• To assess the impact of UCP on bladder capacity, renal function, and spontaneous micturition in boys with PUV.

Main Methods:

• Retrospective analysis of 10 boys with PUV who underwent UCP between 2004 and 2019.
• Evaluation of pre- and postoperative data including kidney and bladder function, SWRD scores, and complications.
• Assessment of long-term follow-up data, including spontaneous micturition and need for further augmentation.

Main Results:

• UCP resulted in a mean 25% increase in age-adjusted bladder capacity.
• Eight out of ten boys achieved spontaneous micturition post-UCP.
• No severe hydronephrosis or need for conversion to intestinal augmentation was observed.
• The SWRD score showed a significant median decrease, indicating improved bladder-rectum coordination.

Conclusions:

• Ureterocytoplasty (UCP) is a safe and effective surgical option for improving bladder capacity in boys with posterior urethral valves (PUV).
• UCP can preserve or improve renal function and maintain the potential for natural micturition.
• This technique offers a viable alternative to intestinal augmentation for select pediatric patients with PUV.